118 related articles for article (PubMed ID: 24015711)
1. Antibodies to N-homocysteinylated albumin and haemoglobin in patients with rheumatoid arthritis: a potential new marker of disease severity.
Nowakowska-Plaza A; Potaczek DP; Gluszko P; Undas A
Scand J Rheumatol; 2014; 43(1):17-21. PubMed ID: 24015711
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against N-homocysteinylated proteins in patients on long-term haemodialysis.
Undas A; Kolarz M; Kopec G; Glowacki R; Placzkiewicz-Jankowska E; Tracz W
Nephrol Dial Transplant; 2007 Jun; 22(6):1685-9. PubMed ID: 17317712
[TBL] [Abstract][Full Text] [Related]
3. [Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus].
Padjas A; Undas A; Swadzba J; Musiał J
Pol Arch Med Wewn; 2007 Mar; 117(3):20-5. PubMed ID: 17718048
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men.
Undas A; Jankowski M; Twardowska M; Padjas A; Jakubowski H; Szczeklik A
Thromb Haemost; 2005 Feb; 93(2):346-50. PubMed ID: 15711753
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against N-homocysteinylated proteins and their determinants in patients on long-term hemodialysis.
Kolarz M; Wyroślak J; Zbróg Z; Kraśniak A; Rogulska J; Padjas A
Pol Arch Med Wewn; 2010 Jun; 120(6):223-30. PubMed ID: 20567206
[TBL] [Abstract][Full Text] [Related]
6. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
[TBL] [Abstract][Full Text] [Related]
7. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
Alexiou I; Germenis A; Ziogas A; Theodoridou K; Sakkas LI
BMC Musculoskelet Disord; 2007 Apr; 8():37. PubMed ID: 17448247
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
10. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
[TBL] [Abstract][Full Text] [Related]
11. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
Korendowych E; Owen P; Ravindran J; Carmichael C; McHugh N
Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
[TBL] [Abstract][Full Text] [Related]
12. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
13. Association of homocysteine with immunological-inflammatory and metabolic laboratory markers and factors in relation to hyperhomocysteinaemia in rheumatoid arthritis.
Yang X; Gao F; Liu Y
Clin Exp Rheumatol; 2015; 33(6):900-3. PubMed ID: 26690891
[TBL] [Abstract][Full Text] [Related]
14. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against Nε-homocysteinylated proteins in patients on different methods of renal replacement therapy.
Kolarz M; Małyszko J; Stompór T; Całka A; Undas A; Myśliwiec M
Clin Chem Lab Med; 2013 May; 51(5):1093-9. PubMed ID: 23183756
[TBL] [Abstract][Full Text] [Related]
17. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
18. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
20. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
Chen HA; Lin KC; Chen CH; Liao HT; Wang HP; Chang HN; Tsai CY; Chou CT
Ann Rheum Dis; 2006 Jan; 65(1):35-9. PubMed ID: 15975966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
